Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bone Diseases, Metabolic

• FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA
• Senolytics to Improve Osteoporosis Therapy
• Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
• Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients
• Denosumab vs Zoledronate After Lumbar Fusion
• Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia: an 1-year Randomized Controlled Trial
• The Effect of Effervescent Alendronate on Bone Turnover
• CBD in Postmenopausal Women With Osteopenia
• Efficacy of Intensive Cholecalciferol Monitoring and Supplementation on Serum vitD Levels in Pediatric Patients With CF
• Vitamin D Status and Bone Metabolism Status in Children With Congenital Epidermolysis Bullosa
• Bisphosphonate Use to Mitigate Bone Loss
• Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa
• Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity
• Romosozumab in Women With Chronic SCI
• A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin
• The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
• Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging
• Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
• Melatonin and Osteogenic Loading on Osteopenia
• Alendronate Versus Denosumab in Kidney Transplant Patients
• Denosumab to Prevent High-Turnover Bone Loss After Bariatric Surgery
• Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid
• Effect of a Ghrelin Receptor Agonist on Muscle and Bone
• Effects of SHR-1222 on Vascular Inflammatory Factors in Patients With Low Bone Mass
• Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
• Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)
• Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
• Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor
• The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.
• Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women
• Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
• Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
• Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients
• Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia
• A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
• PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia
• Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women
• Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
• Heartland Osteoporosis Prevention Study
• Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
• Vitamin D Deficiency in Elderly African American Women in Central Texas
• Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Protease Inhibitors To Dolutegravir In HIV-1-Infected Subjects With Low Bone Mineral Density
• The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
• Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
• A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)
• Bone Metabolism After Laparoscopic Gastric Bypass Surgery (BABS)
• Study of Growth Hormone and Bone in Obesity
• Treatment of Osteopenia With Melatonin
• Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability
• Investigating a New Way of Giving Medicine to Newborn and Preterm Babies
• Stem Cell Recruitment in Osteoporosis Therapy
• Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone
• Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass
• Testosterone and Alendronate in Hypogonadal Men
• Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density
• IGF-1 and Bone Loss in Women With Anorexia Nervosa
• Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women
• Effects of Denosumab on the Pharmacokinetics of Etanercept
• A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis
• Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids
• Classic Yin and Yang Tonic Formula for Osteopenia
• Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)
• Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
• Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease
• µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis
• A Study of LY2541546 in Women With Low Bone Mineral Density
• A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women
• An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
• A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women
• A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
• Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
• A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass
• Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
• Alendronate in Juvenile Osteoporosis
• A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women
• Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
• A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab
• A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
• Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
• Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
• Zoledronate for Osteopenia in Pediatric Crohn's
• Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty
• Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
• A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
• Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
• Prevention of Post Operative Bone Loss in Children
• Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD
• Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
• Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
• A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.
• Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
• Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women
• High Dosage Vitamin D and Osteoporosis
• Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis
• Osteoporosis Prevention With Low Dose Alendronate
• Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
• Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
• Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)
• Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method
• The Effects of Potassium Citrate on Bone Metabolism
• Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women
• Risedronate in Postmenopausal Women With Low Bone Density
• A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
• Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women
• An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density
• 3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
• A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
• Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
• Alendronate Osteoporosis Study
• A Taiwan Isoflavone Multicenter Study (TIMS)
• Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
• Network Osteoporosis Study
• Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
• Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
• Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.
• Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study)
• Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
• Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
• Texture Analysis for Postmenopausal Osteoporosis
• Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
• To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal Women
• Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older
• A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia
• Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
• Osteopenia and Renal Osteodystrophy: Evaluation and Management
• Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density
• AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
• Adding Phosphorus to Osteoporosis Drug Treatment
• Once Weekly Parathyroid Hormone for Osteoporosis
• Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women
• Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
• Encouraging Calcium Absorption and Bone Formation During Early Puberty
• Bone Loss in Premenopausal Women With Depression
• Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
• Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis